109 related articles for article (PubMed ID: 27803285)
21. Thymocyte selection: chemokine signaling is not only about the destination.
Gleimer M; von Boehmer H
Curr Biol; 2010 Apr; 20(7):R316-8. PubMed ID: 20392421
[TBL] [Abstract][Full Text] [Related]
22. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
23. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.
Friand V; Haddad O; Papy-Garcia D; Hlawaty H; Vassy R; Hamma-Kourbali Y; Perret GY; Courty J; Baleux F; Oudar O; Gattegno L; Sutton A; Charnaux N
Glycobiology; 2009 Dec; 19(12):1511-24. PubMed ID: 19717493
[TBL] [Abstract][Full Text] [Related]
24. Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.
Prasad A; Qamri Z; Wu J; Ganju RK
J Leukoc Biol; 2007 Sep; 82(3):465-76. PubMed ID: 17565045
[TBL] [Abstract][Full Text] [Related]
25. Solubilization of the chemokine receptor CXCR4.
Staudinger R; Bandres JC
Biochem Biophys Res Commun; 2000 Jul; 274(1):153-6. PubMed ID: 10903911
[TBL] [Abstract][Full Text] [Related]
26. CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans.
Santiago B; Baleux F; Palao G; Gutiérrez-Cañas I; Ramírez JC; Arenzana-Seisdedos F; Pablos JL
Arthritis Res Ther; 2006; 8(2):R43. PubMed ID: 16507142
[TBL] [Abstract][Full Text] [Related]
27. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
28. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
29. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour.
van der Meulen AA; Biber K; Lukovac S; Balasubramaniyan V; den Dunnen WF; Boddeke HW; Mooij JJ
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):579-91. PubMed ID: 19627512
[TBL] [Abstract][Full Text] [Related]
30. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.
Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH
J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686
[TBL] [Abstract][Full Text] [Related]
31. Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment.
Ocaña E; Pérez-Requena J; Bohórquez JC; Brieva JA; Rodríguez C
Atherosclerosis; 2008 Oct; 200(2):264-70. PubMed ID: 18281050
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
[TBL] [Abstract][Full Text] [Related]
33. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
34. Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.
Monneau YR; Luo L; Sankaranarayanan NV; Nagarajan B; Vivès RR; Baleux F; Desai UR; Arenzana-Seidedos F; Lortat-Jacob H
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29070611
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Feb; 280(4):1003-7. PubMed ID: 11162626
[TBL] [Abstract][Full Text] [Related]
36. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
[TBL] [Abstract][Full Text] [Related]
37. Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration.
Masztalerz A; Zeelenberg IS; Wijnands YM; de Bruijn R; Drager AM; Janssen H; Roos E
J Cell Sci; 2007 Jan; 120(Pt 2):219-28. PubMed ID: 17179206
[TBL] [Abstract][Full Text] [Related]
38. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
[TBL] [Abstract][Full Text] [Related]
39. The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.
Puchert M; Engele J
Cell Tissue Res; 2014 Feb; 355(2):239-53. PubMed ID: 24292718
[TBL] [Abstract][Full Text] [Related]
40. Cxcr7 controls neuronal migration by regulating chemokine responsiveness.
Sánchez-Alcañiz JA; Haege S; Mueller W; Pla R; Mackay F; Schulz S; López-Bendito G; Stumm R; Marín O
Neuron; 2011 Jan; 69(1):77-90. PubMed ID: 21220100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
